233 related articles for article (PubMed ID: 26832338)
21. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.
Kittelberger K; Hur EE; Sazegar S; Keshavan V; Kocsis B
Brain Struct Funct; 2012 Apr; 217(2):395-409. PubMed ID: 21979451
[TBL] [Abstract][Full Text] [Related]
22. Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice.
Uzbay IT; Wallis CJ; Lal H; Forster MJ
Behav Brain Res; 2000 Feb; 108(1):57-61. PubMed ID: 10680757
[TBL] [Abstract][Full Text] [Related]
23. Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD.
Fredriksson A; Archer T
Neurotox Res; 2004; 6(6):435-56. PubMed ID: 15639778
[TBL] [Abstract][Full Text] [Related]
24. Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.
Hillhouse TM; Negus SS
Eur J Pain; 2016 Sep; 20(8):1229-40. PubMed ID: 26914635
[TBL] [Abstract][Full Text] [Related]
25. Brain NMDA Receptors in Schizophrenia and Depression.
Adell A
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585886
[TBL] [Abstract][Full Text] [Related]
26. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice.
Jeon SJ; Kim E; Lee JS; Oh HK; Zhang J; Kwon Y; Jang DS; Ryu JH
Neuropharmacology; 2017 Nov; 126():168-178. PubMed ID: 28899728
[TBL] [Abstract][Full Text] [Related]
27. Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.
Owolabi RA; Akanmu MA; Adeyemi OI
Neurosci Lett; 2014 Apr; 566():172-6. PubMed ID: 24530380
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
[TBL] [Abstract][Full Text] [Related]
29. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin.
Gao M; Jin W; Qian Y; Ji L; Feng G; Sun J
Cytokine; 2011 Nov; 56(2):458-65. PubMed ID: 21795061
[TBL] [Abstract][Full Text] [Related]
30. NMDA receptor antagonists attenuate the proconvulsant effect of juvenile social isolation in male mice.
Amiri S; Haj-Mirzaian A; Amini-khoei H; Momeny M; Shirzadian A; Rahimi-Balaei M; Zarrinrad G; Ghazi-Khansari M; Azizi R; Dehpour AR; Mehr SE
Brain Res Bull; 2016 Mar; 121():158-68. PubMed ID: 26836272
[TBL] [Abstract][Full Text] [Related]
31. Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.
Lemercier CE; Holman C; Gerevich Z
Schizophr Res; 2017 Oct; 188():118-124. PubMed ID: 28109667
[TBL] [Abstract][Full Text] [Related]
32. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
[TBL] [Abstract][Full Text] [Related]
33. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Maeng S; Zarate CA; Du J; Schloesser RJ; McCammon J; Chen G; Manji HK
Biol Psychiatry; 2008 Feb; 63(4):349-52. PubMed ID: 17643398
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of NMDA receptor antagonism on spine density.
Ruddy RM; Chen Y; Milenkovic M; Ramsey AJ
Synapse; 2015 Jan; 69(1):52-6. PubMed ID: 25220437
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.
Yang B; Ren Q; Ma M; Chen QX; Hashimoto K
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608811
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction between N-methyl-D-aspartate receptor and ascorbic acid during neuropathic pain induced by chronic constriction injury of the sciatic nerve.
Saffarpour S; Nasirinezhad F
J Basic Clin Physiol Pharmacol; 2017 Nov; 28(6):601-608. PubMed ID: 28902622
[TBL] [Abstract][Full Text] [Related]
37. Blockade of tolerance to stress-induced analgesia by MK-801 in mice.
Vaccarino AL; Clavier MC
Pharmacol Biochem Behav; 1997 Mar; 56(3):435-9. PubMed ID: 9077580
[TBL] [Abstract][Full Text] [Related]
38. Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice.
Suzuki T; Aoki T; Kato H; Yamazaki M; Misawa M
Eur J Pharmacol; 1999 Dec; 385(2-3):99-102. PubMed ID: 10607864
[TBL] [Abstract][Full Text] [Related]
39. Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine.
Fredriksson A; Archer T
Neurotox Res; 2003; 5(7):549-64. PubMed ID: 14715439
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.
Pei JC; Hung WL; Lin BX; Shih MH; Lu LY; Luo DZ; Tai HC; Studer V; Min MY; Lai WS
J Psychopharmacol; 2019 Oct; 33(10):1288-1302. PubMed ID: 31294644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
